Iron status and the outcome of HIV infection: an overview.

Gordeuk, V R; Delanghe, J R; Langlois, M R; Boelaert, J R

Gordeuk, V R; Delanghe, J R; Langlois, M R; Boelaert, J R.

Affiliation

Gordeuk VR; Center for Sickle Cell Disease and Department of Medicine, Howard University College of Medicine, Washington, DC 20059, USA.

J Clin Virol ; 20(3): 111-5, 2001 Feb.

Article in En | MEDLINE | ID: mdl-11166657

Subject(s)

Acquired Immunodeficiency Syndrome/pathology; HIV-1; Iron/metabolism; AIDS-Related Opportunistic Infections/pathology; AIDS-Related Opportunistic Infections/prevention & control; Acquired Immunodeficiency Syndrome/complications; Acquired Immunodeficiency Syndrome/metabolism; Anti-Infective Agents/therapeutic use; Bone Marrow/metabolism; Chelating Agents/therapeutic use; Clinical Trials as Topic; Dapsone/therapeutic use; Deferoxamine/therapeutic use; Haptoglobins/genetics; Humans; Iron/blood; Polymorphism, Genetic; Survival Rate; beta-Thalassemia/complications; beta-Thalassemia/drug therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Acquired Immunodeficiency Syndrome / HIV-1 / Iron Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Clin Virol Journal subject: VIROLOGIA Year: 2001 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links